AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,575,000 | -3.7% | 18,700 | -6.5% | 0.03% | +17.9% |
| Q1 2018 | $1,635,000 | +697.6% | 20,000 | +455.6% | 0.03% | +833.3% |
| Q4 2017 | $205,000 | -98.2% | 3,600 | -97.8% | 0.00% | -97.6% |
| Q3 2017 | $11,120,000 | +364.9% | 166,600 | +258.3% | 0.13% | +252.8% |
| Q2 2017 | $2,392,000 | -42.4% | 46,500 | -34.6% | 0.04% | -42.9% |
| Q1 2017 | $4,152,000 | +90.4% | 71,100 | +72.2% | 0.06% | -12.5% |
| Q3 2016 | $2,181,000 | +426.8% | 41,300 | +304.9% | 0.07% | +260.0% |
| Q1 2016 | $414,000 | – | 10,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |